Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,796 | 13,616 | 7,797 | 88,756 | 34,607 |
| Receivables | N/A | N/A | N/A | 806 | N/A |
| TOTAL | $20,693 | $16,348 | $10,717 | $91,247 | $42,297 |
| Non-Current Assets | |||||
| PPE Net | 483 | 717 | 1,147 | 451 | 156 |
| Investments And Advances | 0 | 0 | 0 | 723 | 822 |
| Other Non-Current Assets | 7,002 | 10,081 | 10,800 | 4,092 | 4,072 |
| TOTAL | $7,485 | $10,798 | $11,947 | $5,266 | $5,050 |
| Total Assets | $28,178 | $27,146 | $22,664 | $96,513 | $47,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 260 |
| Accounts payable and accrued liabilities | 1,038 | 4,369 | 2,805 | 4,710 | 5,578 |
| Accrued Expenses | 8,415 | 3,757 | 1,935 | 3,219 | 6,665 |
| Other current liabilities | 1,169 | 719 | 1,436 | 114 | 39,223 |
| TOTAL | $11,523 | $9,755 | $6,868 | $11,296 | $107,449 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 635 |
| Deferred Revenues | N/A | N/A | N/A | 2,301 | 3,942 |
| Other Non-Current Liabilities | 27,967 | 6,018 | 6,881 | 3,475 | 3,847 |
| TOTAL | $27,967 | $6,018 | $6,881 | $3,710 | $30,347 |
| Total Liabilities | $39,490 | $15,773 | $13,749 | $15,006 | $137,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,954 | 10,235 | 3,011 | 2,996 | N/A |
| Common Shares | 110 | 96 | 3 | 300 | 156 |
| Retained earnings | -194,101 | -142,203 | -107,008 | -215,135 | -160,562 |
| Other shareholders' equity | -325 | -347 | 111,060 | -103 | -179 |
| TOTAL | $-11,312 | $11,373 | $8,915 | $81,507 | $-90,449 |
| Total Liabilities And Equity | $28,178 | $27,146 | $22,664 | $96,513 | $47,347 |